Charles River Laboratories Schedules First-Quarter 2023 Earnings Release and Conference Call

Rhea-AI Summary

Charles River Laboratories International, Inc. (NYSE: CRL) will release its first-quarter 2023 financial results on May 11, before the market opens. A conference call to discuss the results is scheduled for 8:30 a.m. ET on the same day. Investors can listen to the live webcast through the Investor Relations section of the company's website, with a replay available afterward.

Charles River provides critical products and services to pharmaceutical and biotechnology companies, government agencies, and academic institutions worldwide. Their focus is on enhancing research and drug development processes to assist in the discovery and safe manufacture of new therapies.

Positive

• Scheduled release of first-quarter financial results.
• Opportunity for investors to participate in a live conference call.
• Company's strong position in supporting drug development and research.

Negative

• None.

WILMINGTON, Mass.--(BUSINESS WIRE)-- Charles River Laboratories International, Inc. (NYSE: CRL) will release first-quarter 2023 financial results on Thursday, May 11^th, before the market opens. A conference call has been scheduled to discuss this information on Thursday, May 11^th, at 8:30 a.m. ET.

Investors will have the opportunity to listen to a live webcast of the conference call through the Investor Relations section of the Company's website at ir.criver.com. A replay will be accessible through the same website.

About Charles River

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230411005145/en/

Investor Relations:

Todd Spencer

Corporate Vice President, Investor Relations

781.222.6455

todd.spencer@crl.com

Source: Charles River Laboratories International, Inc.

FAQ

When will Charles River Laboratories release their first quarter 2023 financial results?

Charles River Laboratories will release their first-quarter 2023 financial results on May 11, before the market opens.

What time is the conference call for Charles River Laboratories' Q1 results?

The conference call for Charles River Laboratories' Q1 results is scheduled for 8:30 a.m. ET on May 11.

How can investors access the conference call for Charles River Laboratories?

Investors can access the conference call via a live webcast on the Investor Relations section of Charles River's website.

What services does Charles River Laboratories provide?

Charles River Laboratories provides essential products and services to help accelerate research and drug development for pharmaceutical and biotechnology companies.